Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study

Objective To compare the 1-year retention rate of secukinumab in axial spondyloarthritis (axSpA) and its predisposing factors with regard to its time of initiation (eg, right after or remotely from its launch).Methods Study design: Retrospective multicentre French study of patients with axSpA. Study...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Maxime Dougados, Pascal Claudepierre, Philippe Goupille, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas, Adeline Ryussen-Witrand, Emilie Desfleurs, Audrey Lardy-Cleaud
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMJ Publishing Group 2024-02-01
Reeks:	RMD Open
Online toegang:	https://rmdopen.bmj.com/content/10/1/e003942.full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!